CMPX
Compass Therapeutics, Inc.
+0.08 (+4.37%)1.91USD1.1M成交股數344M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | 0.00-100% | 0.00 | – | 0.00 | 850K | – | – | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 19.6M | 13.4M | 13.7M | 12.8M | 16.4M | 13.1M | 8.6M | 11.2M | 9.5M | 12.4M | 8.8M | 10.2M |
| 銷售管理費用 | 7.4M | 6.9M | 4.3M | 3.0M | 4.7M | 4.9M | 3.6M | 4.7M | 3.2M | 3.0M | 3.1M | 3.1M |
| 營業利益 | −27.0M+28% | −20.3M+13% | −18.0M+47% | −15.8M+5% | −21.1M+65% | −18.0M+17% | −12.2M+3% | −15.0M+13% | −12.8M | −15.4M | −11.9M | −13.3M |
| 營業利益率 | – | – | – | – | – | – | – | -1,770.0% | – | – | – | – |
| 稅後淨利 | −25.2M+27% | −18.3M+10% | −15.7M+50% | −14.3M+9% | −19.9M+84% | −16.6M+24% | −10.5M+5% | −13.1M+16% | −10.8M | −13.4M | −10.0M | −11.3M |
| 淨利率 | – | – | – | – | – | – | – | -1,538.4% | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | 138M | 138M | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 35.5M | 55.2M | 30.6M | 46.2M | 22.9M | 41.0M | 19.4M | 19.4M | 43.5M | 24.2M | 30.4M | 19.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 190M | 205M | 220M | 231M | 117M | 131M | 149M | 156M | 161M | 157M | 170M | 179M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 24.1M | 18.7M | 22.8M | 21.6M | 23.5M | 21.2M | 10.8M | 9.5M | 4.1M | 8.3M | 10.0M | 10.9M |
| 股東權益 | 166M | 186M | 197M | 210M | 93.2M | 110M | 138M | 146M | 157M | 149M | 160M | 168M |
| 負債比 | 12.7% | 9.1% | 10.4% | 9.4% | 20.1% | 16.1% | 7.2% | 6.1% | 2.5% | 5.3% | 5.9% | 6.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −17.3M+31% | – | – | – | −13.2M | – | – | −13.9M | – | – | – |
| 資本支出 | – | 82K | – | – | – | 18K | – | – | 0.00 | – | – | – |
| 自由現金流 | – | −17.4M+31% | – | – | – | −13.2M | – | – | −13.9M | – | – | – |
| 折舊攤銷 | – | 15K | – | – | – | 140K | – | – | 154K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −66.5M | –% | – | −49.2M |
| FY2024 | 850K | – | −49.4M | -5,808.8% | – | −44.9M |
| FY2023 | 0.00 | – | −42.5M | –% | – | −40.6M |
| FY2022 | – | – | −39.2M | –% | – | −34.3M |
| FY2021 | – | – | −82.2M | –% | -1.31 | −21.2M |
| FY2020 | – | – | −29.5M | –% | -0.96 | −26.9M |
| FY2020 | – | – | −37K | –% | -0.01 | – |
| FY2019 | – | – | −34.7M | –% | -5.19 | −32.2M |